Literature DB >> 9694337

Prognostic factors in medulloblastoma.

M T Giordana1, P Schiffer, D Schiffer.   

Abstract

Medulloblastoma is a highly malignant cerebellar tumor of children and, less frequently, of adults, with a tendency to early recurrence and dissemination through the cerebrospinal fluid. The prognosis has improved significantly in recent decades, in parallel with the improvement in neurosurgical techniques and the use of postoperative radiotherapy. An overview is given of the prognostic role of clinical and pathological features of individual cases as reported in the literature. Apart from the presence or absence of metastases at diagnosis and the radiotherapy modality, none of the factors studied was generally thought to have a definite significant prognostic role. The extent of surgical excision seems to influence survival more in pediatric cases than in adults. Ongoing cytogenetic studies and molecular biology investigations are aimed at better categorization of medulloblastomas and individualized postoperative treatment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694337     DOI: 10.1007/s003810050221

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  12 in total

1.  Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994-2003.

Authors:  D Kombogiorgas; S Sgouros; A R Walsh; A D Hockley; M Stevens; R Grundy; A Peet; M English; D Spooner
Journal:  Childs Nerv Syst       Date:  2006-11-22       Impact factor: 1.475

Review 2.  [Infratentorial tumors].

Authors:  I Q Grunwald; C Veith; M Backens; C Roth; P Papanagiotou; W Reith
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

3.  Appraisal of the current staging system for residual medulloblastoma by volumetric analysis.

Authors:  Dimitris Kombogiorgas; Stephanie Puget; Nathalie Boddaert; Andrew Peet; Martin English; Kal Natarajan; Jacques Grill; Dominique Couanet; Christian Sainte-Rose; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2011-08-04       Impact factor: 1.475

4.  Differential proliferative index of cancer stem-like cells in primary and recurrent medulloblastoma in human.

Authors:  Xuqun Tang; Yu Yao; Jingjing Zhu; Kunlin Jin; Yin Wang; Ying Mao; Liangfu Zhou
Journal:  Childs Nerv Syst       Date:  2012-07-20       Impact factor: 1.475

5.  Heparanase expression and TrkC/p75NTR ratios in human medulloblastoma.

Authors:  Neeta D Sinnappah-Kang; Robert E Mrak; Daniel B Paulsen; Dario Marchetti
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

6.  Chemotherapy increases long-term survival in patients with adult medulloblastoma--a literature-based meta-analysis.

Authors:  Selin Kocakaya; Christoph Patrick Beier; Dagmar Beier
Journal:  Neuro Oncol       Date:  2015-09-10       Impact factor: 12.300

7.  Differential expression of somatostatin receptors in medulloblastoma.

Authors:  J Guyotat; J Champier; G S Pierre; A Jouvet; P Bret; C Brisson; M F Belin; F Signorelli; M F Montange
Journal:  J Neurooncol       Date:  2001-01       Impact factor: 4.130

8.  Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.

Authors:  Chitra Sarkar; Pulakesh Pramanik; Asis Kumar Karak; Partho Mukhopadhyay; Mehar Chand Sharma; Varindera Paul Singh; Veer Singh Mehta
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

9.  Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.

Authors:  Hye Lim Jung; Kyu-Chang Wang; Seung-Ki Kim; Ki Woong Sung; Hong Hoe Koo; Hee Young Shin; Hyo Seop Ahn; Hyung Jin Shin; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

10.  Cancer-testis (CT) antigen expression in medulloblastoma.

Authors:  Sueli M Oba-Shinjo; Otavia L Caballero; Achim A Jungbluth; Sergio Rosemberg; Lloyd J Old; Andrew J G Simpson; Suely K N Marie
Journal:  Cancer Immun       Date:  2008-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.